Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: R/S is NEVER a good idea. Lazy method to improve SP! Consider the following:

I concur 100% It guarantees nothing....not price nor a listing. Earnings success has to be in place for some time and the market and investors have to have confidence in continued success. imo A R/S should never be instituted as a strategy to achieve a listing. For it to work, the share price should already be rising due to solid performance.....and so if that is the case, why not just leave it alone. Deciding on a R/S from a position of weakness is doomed to fail. I know most here already know and agree with what I expressed but I repeat it because after all these years, I cannot fathom my investment being potentially sabotaged by this type of action.

Share
New Message
Please login to post a reply